Besides the alterations described above, high occurrence of losses involving CDKN2A gene have been reported in gliomas, ranging from 11% to 71% in all histological types, although more frequently found in astrocytomas [41,42,43]. This evidence concerns the gene CDKN2A and astrocytoma (excluding glioblastoma).